Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas

Clinical trial NCT00003797 · UNKNOWN

Trial details

NCT number: NCT00003797
Sponsor: Brown University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 1999-03-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.